Anzeige
Mehr »
Montag, 27.07.2026 - Börsentäglich über 12.000 News
Das Pentagon sucht Nickel: China dominiert - ist der Meeresboden die Lösung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
376 Leser
Artikel bewerten:
(1)

Net Medical Xpress Solutions, Inc.: Net Medical Reports Improved Financial Results For 2021

Leaning on two decades of experience connecting providers with the patients who need them, Net Medical's business is unique and growing.

ALBUQUERQUE, NM / ACCESSWIRE / March 14, 2022 / Net Medical (OTC PINK:NMXS) announced today revenues in 2021 of $1.768 million verses revenues of $1,118,000 in 2020. Net income was $10,000 versus a loss of ($499,000) in 2020.

Net Medical CEO Dick Govatski said, "We were pleased to record improved financial results for 2021. Revenues were up 58% and we were profitable for the year. We benefited from new revenue from our medical laboratory services that we believe position us for an even better year in 2022.

"Late in the year, we launched our mobile COVID testing labs in New Mexico. We immediately benefited from strong demand for tests in Albuquerque, Taos and other areas.

"As 2022 is unfolding, we are exploring additional testing programs, expansion into related operations and additional geographic areas of operations. For instance, we are actively investigating whether our mobile testing labs can actively support the Federal government's just announced Test to Treat program, whereby a patient diagnosed with certain illness can be immediately prescription treated. The connection of our vans directly to one of our qualified physicians makes this possible. We also expect shortly to be able to simultaneously provide both PCR and Antigen testing. I expect to have more to say about this in the future," Govatski said.

For more information, call 505-255-1999. X 320. Visit www.netmedical.com. Email ir@netmedical.com

About Net Medical - publicly traded (OTC Pink:NMXS) since 1999.

Net Medical Xpress has two operating units. Net Medical Xpress provides telemedicine solutions for hospitals, nursing homes, specialty hospitals and other medical facilities. The company specializes in teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare and telenephrology. We maintain a 24/7/365 call center, software developers, and telemedicine platforms. In additional, Net Medical Labs is a moderate complex CLIA certified lab that specializes in virus testing and diagnostics. The company's mobile fleet of vans is utilized to provide statewide COVID and FLU testing for schools, companies, homeless shelters, and nursing homes. The lab also serves as a reference lab for physician offices, and other facilities that lack services for complex virus diagnostics.

Forward-Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are the company's current expectations about future events and can be identified by terms such as "plans," "expect," "may," "anticipate," "intend," "should be," "will be," "is likely to," "believes," and similar expressions referring to future periods. The company believes any expectations reflected in the forward-looking statements are reasonable but cannot guarantee future results, level of activity, performance or achievements. Actual results may differ materially from those expressed or implied in the forward-looking statements.

SOURCE: Net Medical Xpress Solutions, Inc.



View source version on accesswire.com:
https://www.accesswire.com/692860/Net-Medical-Reports-Improved-Financial-Results-For-2021

© 2022 ACCESS Newswire
Achtung, Korrektur!
Die Börsen laufen heiß. Trotz geopolitischer Krisen und steigender Zinsen klettern viele Indizes weiter Richtung Allzeithoch. Doch unter der Oberfläche zeigen sich erste Risse: Der Abverkauf bei Halbleiter-, KI- und Space-Aktien macht deutlich, wie schnell sich die Stimmung drehen kann.

Besonders gefährlich ist die aktuelle Gemengelage aus schwacher Saisonalität, dünner Liquidität in den Sommermonaten und historisch hohen Bewertungen. Selbst vermeintlich sichere Blue Chips sind inzwischen teuer bewertet und damit anfällig für Korrekturen. Gleichzeitig liefern technische Indikatoren erste Warnsignale. So werden viele Rekordstände nicht mehr bestätigt.

Für Anleger steigen die Risiken spürbar. Wer jetzt nicht genauer hinschaut, läuft Gefahr, auf dem falschen Fuß erwischt zu werden.

In unserem aktuellen Spezialreport zeigen wir fünf Aktien, bei denen die Abwärtsrisiken besonders hoch sind – und wo sich Gewinnmitnahmen oder sogar Short-Strategien anbieten könnten.

Jetzt den kostenlosen Report sichern – bevor die Korrektur Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.